Anxiety is the #1 relapse trigger in the first year of recovery. The standard answer — benzodiazepines — is literally handing a person in recovery a drug of abuse. Selank is a nasal peptide built for exactly that gap. Early evidence, stated plainly.
Selank is a synthetic peptide investigated for effects on anxiety-related signaling. Proposed mechanisms are research hypotheses, not proof that it stabilizes an individual’s opioid system or treats addiction.
A comparative study involved 60 patients with anxiety-related disorders and compared Selank with phenazepam. This was not a trial of addiction treatment. Its findings do not establish benzodiazepine equivalence for everyone, absence of dependence, or effectiveness against withdrawal.
Anxiety symptoms, substance use, medication effects, and withdrawal can overlap. A clinician should assess the cause rather than assuming a peptide is the appropriate treatment.
Neither a plausible mechanism nor a catalog listing establishes clinical benefit for addiction.
The intake asks about your health and medications so a clinician can assess whether further evaluation is appropriate.
No established addiction dosing protocol is presented here. Any prescription requires clinician-selected formulation, route, strength, and directions.
Do not replace or stop existing treatment based on this page. Discuss symptoms, potential interactions, and follow-up with your clinician.
Intake is available for clinical review. Pharmacy fulfillment and payment setup are not yet verified; starting an intake does not guarantee a prescription or medication delivery.
Start Selank intake →PRODUCT INFORMATION
Answers from this product’s published information. General information, not medical advice. Please leave out personal medical details.
Continue exploring
Soberpedia
